Trialjectory is an artificial intelligence (AI)-powered patient-centric decision-support platform helping to democratize access to advanced cancer treatments. Its unique model empowers cancer patients to own their treatment journey by creating a personalized treatment plan that enhances physician point of care. The SaaS Optimizer platform delivers actionable insights that directly influence trial design, improve operational processes, and marketing communication strategies, while ensuring alignment with patients' needs and expectations. Patients: TrialJectory helps match you with a personalized list of treatment options in minutes for free. TrialJectory makes cancer treatment accessible for everyone. Learn your options: www.trialjectory.com Pharma, Biotech & Med Device: TrialJectory helps biopharma companies become truly patient-centric by sharing patients' unique barriers and motivations while identifying areas for improving and enhancing clinical trial programs. Focusing on patients’ needs has enabled TrialJectory to: Grow our active community members to over 100K by the end of 2022 with 35% diverse patients Decrease enrollment timelines by 20% with prequalified patients. Compile patient-identified barriers to increase enrollment and improve trial design Contact us: Sales@trialjectory.com Patient Advocacy: TrialJectory collaborates with cancer patient advocacy groups and research foundations to combine your expertise in advocacy and education with our AI-powered technology platform to empower cancer patients to find advanced treatment options that fit their precise profile. Contact us: Advocacy@trialjectory.com Physicians/HCPs: We save you hours searching for treatment options for your patients with our AI-powered advanced support platform. Our matched studies can be easily shared between patient and caregiver allowing both to collaborate on care. Contact us: HCP@trialjectory.com